BB
Therapeutic Areas
Propanc Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PRP | Advanced Solid Tumors (Pancreatic, Ovarian) | Phase 1/2 |
Leadership Team at Propanc Biopharma
JN
James Nathanielsz
Chief Executive Officer, Managing Director
SD
Steven D. Neill
Former Chief Financial Officer
DJ
Dr. Julian Kenyon
Former Chief Scientific Officer
DK
Dr. Klaus Kutz
Former Chief Medical Officer
RS
Roland Scollay
Former Board Member
PC
Paul C. H. Lee
Former Board Member